CT-637

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCT-637
Drug Alias NameCT-637
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionHigh Mobility Group Protein B1 inhibitors
TargetsHigh Mobility Group Protein B1
Therapy Area/IndicationsInflammationAutoimmune DiseasesLupus Erythematosus, Systemic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCreabilis Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCreabilis Sa
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune DiseasesLupus Erythematosus, Systemic +[4] 

Other Information

ATC CodeN/A
Related LinksN/A